SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories completes sale of 19.97% equity shares in Optimus

26 Sep 2022 Evaluate

Unichem Laboratories has completed the sale of 19.97% equity shares in Optimus Drugs (Optimus) to Sekhmet Pharmaventures on September 22, 2022. The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche. For the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent.

Incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×